Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (The Framingham Heart Study)

Colleen Sam; Joseph M. Massaro; Ralph B. D’Agostino; Daniel Levy; Jarvis W. Lambert; Philip A. Wolf; Emelia Benjamin

doi:10.1016/j.amjcard.2004.06.038

Related publications

Article1994

Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.

S. M. Vaziri, Martin G. Larson, Emelia Benjamin, Daniel Levy

Article2017

Atrial fibrillation and cognitive decline in the Framingham Heart Study

Arvind Nishtala, Ryan J. Piers, Jayandra J. Himali, Alexa S. Beiser, Kendra Davis‐Plourde, Jane S. Saczynski, David D. McManus, Emelia Benjamin, Rhoda Au

Article2010

Dietary factors and incident atrial fibrillation: the Framingham Heart Study

Jian Shen, Victor M. Johnson, Lisa Sullivan, Paul F. Jacques, Jared W. Magnani, Steven A. Lubitz, Shivda Pandey, Daniel Levy, Ramachandran S. Vasan, Paula A. Quatromoni, Mireia Junyent, José M. Ordovás, Emelia Benjamin

Article2011

Insulin Resistance and Atrial Fibrillation (from the Framingham Heart Study)

João D. Fontes, Asya Lyass, Joseph M. Massaro, Michiel Rienstra, Dhayana Dallmeier, Renate B. Schnabel, Thomas J. Wang, Ramachandran S. Vasan, Steven A. Lubitz, Jared W. Magnani, Daniel Levy, Patrick T. Ellinor, Caroline S. Fox, Emelia Benjamin

Article2012

Age of natural menopause and atrial fibrillation: The Framingham Heart Study

Jared W. Magnani, Carlee Moser, Joanne M. Murabito, Kerrie P. Nelson, João D. Fontes, Steven A. Lubitz, Lisa Sullivan, Patrick T. Ellinor, Emelia Benjamin